Human Health Holdings Limited, an investment holding company, provides healthcare services in Hong Kong. The company offers general practice services, including general consultation, diagnostics and preventative health, minor procedure, vaccination, physical check-up, health education, occupational health advisory, Chinese medicine, work injury assessment, telemedicine, COVID-19 related, outreach services, and healthcare related services and products. It also provides specialty services in the areas of general surgery, orthopedics and traumatology, ophthalmology, otorhinolaryngology, pediatrics, obstetrics and gynecology, gastroenterology and hepatology, respiratory medicine, cardiology, pediatric surgery, dermatology and venereology, psychiatry, radiology, urology, nephrology, neurosurgery, anaesthesiology, and oncology, as well as physiotherapy, clinical psychology, medical aesthetics, nutritionist, health and wellness, endoscopy, and medical diagnostics. In addition, the company offers dental services comprising general dentistry, dental implant, 3D guided implant surgery, crown and bridge, periodontal treatment, prosthodontics, oral surgery, orthodontics, endodontics, cosmetic dentistry, teeth whitening, veneers and laser dentistry, advanced oral and maxillofacial surgery, CAD/CAM dentistry, panoramic radiography, and cone-beam computed tomography services. Further, it provides doctors and dentists agreements management, and medical imaging services. As of June 30, 2021, the company operated 58 medical centers and 103 service points. The company was founded in 1997 and is headquartered in Kowloon, Hong Kong. Human Health Holdings Limited is a subsidiary of Treasure Group Global Limited.
Human Health Dividend Announcement
• Human Health announced a annually dividend of HK$0.03 per ordinary share which will be made payable on 2024-12-30. Ex dividend date: 2024-12-04
• Human Health annual dividend for 2024 was HK$0.03
• Human Health annual dividend for 2023 was HK$0.16
• Human Health's trailing twelve-month (TTM) dividend yield is 19.75%
• Human Health's payout ratio for the trailing twelve months (TTM) is 251.06%
Human Health Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-12-04 | HK$0.03 | annually | 2024-12-30 |
2023-12-11 | HK$0.16 | annually | 2023-12-29 |
2022-12-06 | HK$0.30 | annually | 2022-12-23 |
2021-12-07 | HK$0.12 | annually | 2021-12-28 |
2019-12-03 | HK$0.03 | annually | 2019-12-23 |
2018-12-04 | HK$0.03 | annually | 2018-12-21 |
2017-12-04 | HK$0.02 | annually | 2017-12-21 |
2016-12-01 | HK$0.03 | annually |
Human Health Dividend per year
Human Health Dividend growth
Human Health Dividend Yield
Human Health current trailing twelve-month (TTM) dividend yield is 19.75%. Interested in purchasing Human Health stock? Use our calculator to estimate your expected dividend yield:
Human Health Financial Ratios
Human Health Dividend FAQ
Other factors to consider when evaluating Human Health as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Human Health stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Human Health's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Human Health publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Human Health distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Human Health are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Human Health sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Human Health distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Human Health declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Human Health's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Human Health's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.